Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase 1b Randomized Trial and Follow-Up Study in Uganda of the Blood-Stage Malaria Vaccine Candidate BK-SE36
Authors
Keywords
Malaria, Malarial parasites, Vaccination and immunization, Antibodies, Vaccines, Enzyme-linked immunoassays, Parasitemia, Parasitic diseases
Journal
PLoS One
Volume 8, Issue 5, Pages e64073
Publisher
Public Library of Science (PLoS)
Online
2013-05-29
DOI
10.1371/journal.pone.0064073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global malaria mortality between 1980 and 2010: a systematic analysis
- (2012) Christopher JL Murray et al. LANCET
- A review of malaria vaccine clinical projects based on the WHO rainbow table
- (2012) Lauren Schwartz et al. MALARIA JOURNAL
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5
- (2012) Kazuyuki Tanabe et al. VACCINE
- Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura
- (2012) Meral Esen et al. VACCINE
- Malaria in Uganda: Challenges to control on the long road to elimination
- (2011) Adoke Yeka et al. ACTA TROPICA
- Continuing Intense Malaria Transmission in Northern Uganda
- (2011) Carla Proietti et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Malaria vaccines and the new malaria agenda
- (2011) B.M. Greenwood et al. CLINICAL MICROBIOLOGY AND INFECTION
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate
- (2011) Nirianne Marie Q. Palacpac et al. VACCINE
- A Research Agenda for Malaria Eradication: Vaccines
- (2011) PLOS MEDICINE
- Advances and challenges in malaria vaccine development
- (2010) Peter D. Crompton et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36
- (2010) Toshihiro Horii et al. PARASITOLOGY INTERNATIONAL
- Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP142-C1/Alhydrogel with and without CPG 7909 in Malaria Naïve Adults
- (2010) Ruth D. Ellis et al. PLoS One
- The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia
- (2009) Jean-Pierre Van Geertruyden et al. MALARIA JOURNAL
- Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso
- (2009) I. NEBIE et al. PARASITE IMMUNOLOGY
- Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
- (2009) Caterina Guinovart et al. PLoS One
- Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
- (2009) Sodiomon B. Sirima et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search